Clinical Trials
9 trialsNCT06554795 2026-06-05
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
DualityBio Inc.
Phase 1/2 Recruiting
NCT06977737 2026-05-22
ATTEST
Accession Therapeutics Limited
Phase 1/2 Recruiting
NCT06144671 2026-04-27
GT201 Injection For The Treatment Of Advanced Solid Tumors
Grit Biotechnology
Phase 1/2 Recruiting
NCT04219254 2026-04-15
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
BioInvent International AB
Phase 1/2 Recruiting
NCT05689853 2026-03-18
Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors
Akeso
Phase 1/2 Recruiting
NCT06265727 2026-01-08
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Corbus Pharmaceuticals Inc.
Phase 1/2 Recruiting
NCT06088004 2025-08-22
Phase â… /â…¡ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors
Suzhou Abogen Biosciences Co., Ltd.
Phase 1/2 Recruiting
NCT06895733 2025-03-26
Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)
Tianjin Medical University Second Hospital
Phase 1/2 Recruiting
NCT06622486 2024-11-07
First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors
Egle Therapeutics
Phase 1/2 Recruiting